Use of methylphenidate in alzheimer’s dementia: Effect on apathy
Introduction Alzheimer’s Disease (AD) is associated with neuropsychiatric symptoms such as agitation depression and apathy. It has been proposed that the pathophysiology of apathy, that is defined as quantitative reduction in goal-directed activity compared with previous functioning, in AD is asso...
Main Authors: | R. Borralho, C. Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821011354/type/journal_article |
Similar Items
-
An Update on Apathy in Alzheimer’s Disease
by: Helena Dolphin, et al.
Published: (2023-07-01) -
Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review
by: Christos G. Theleritis, et al.
Published: (2019-10-01) -
The Differential Role of Executive Apathy in Alzheimer’s Disease Dementia, Mild Cognitive Impairment and Healthy Cognitive Ageing
by: Michalis Mougias, et al.
Published: (2023-03-01) -
Apathy in Alzheimer's disease: Contribution to a clinical view on progression of dementia
by: Florindo Stella, et al. -
Brazilian caregiver version of the Apathy Scale
by: Henrique Cerqueira Guimarães, et al.